CTM founder buys more shares amidst short sell attack

CTM founder buys more shares amidst short sell attack

After losing more than $120 million from a hedge fund "ambush" of his company, Corporate Travel Management ('CTM', ASX: CTD) CEO Jamie Pherous (pictured) is reinvesting in the business he founded.

After the group released an Ernst & Young-backed defence of its financial health, on Friday Pherous acquired 115,000 shares for a value of more than $2.4 million which now takes his total holdings close to $450 million.

At the time of writing Friday's purchase had made him around $83,000.

Two days after CTM's crisis-mode Halloween AGM where an explanation of North American operations was a dominant theme, US-based independent non-executive director Admiral Robert J Natter acquired 12,000 shares for a value of $269,884.

Admiral Natter is yet to make a profit on that transaction, but his total holdings are now worth around $2.58 million.

Today, Corporate Travel Management announced that Bennelong Australian Equity Partners had become a substantial shareholder in the company with more than 5.7 million securities, giving it a voting power of close to 5.3 per cent.

Bennelong's shareholdings represent RBC, RBC Lux, NAS, Citi and BNP.

Despite the negative press that has surrounded the company following its attack from VGI Partners, Morgan Stanley believes CTM's prospects are strong and has set a price target of $27.

In a research brief after the EY review of CTM, Morgan Stanley noted several points including consistency in working capital with total transaction value (TTV), emphasising "the latest investor concerns do not accurately reflect payments & receipts".

Morgan Stanley noted cash generation would be a key driver for the company in FY19, and also pointed to CTM's clarification that its total staff numbers were 2666 as compared to 2750 as stated on its site.

Meanwhile, Macquarie Wealth Management is confident CTM has responded to all matters raised by VGI but highlights near-term perception has been hit, setting a 12-month price target of $24.50. Nonetheless, its action recommendations remains "neutral", with the belief the stock is fairly valued. 

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Enjoyed this article?

Don't miss out on the knowledge and insights to be gained from our daily news and features.

Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.

Support independent journalism and stay informed with stories that matter to you.

Subscribe now and get 50% off your first year!

WorldFirst offers fast and secure cross-border payments to boost global sales for SMEs
Partner Content
WorldFirst, a one-stop digital payment and financial services platform for global busin...
Advertisement

Related Stories

Aussie alcohol-free brand Naked Life Spirts strikes deal with Molson Coors to launch in US

Aussie alcohol-free brand Naked Life Spirts strikes deal with Molson Coors to launch in US

Fresh from a $3 million crowdfunding equity raise last year, Melbou...

Needle-free biotech Vaxxas seals $43m from US Government for its largest trial yet

Needle-free biotech Vaxxas seals $43m from US Government for its largest trial yet

Needle-free vaccine company Vaxxas is being supported by a US Gover...

Nine boss Mike Sneesby steps down after one of his ‘most challenging years’

Nine boss Mike Sneesby steps down after one of his ‘most challenging years’

Nine Entertainment Co (ASX: NEC) boss Mike Sneesby will step down a...

Reece Group buys Melbourne venture studio Shadowboxer and its Southpaw web agency

Reece Group buys Melbourne venture studio Shadowboxer and its Southpaw web agency

The innovation division of Reece Group (ASX: REH) has acquired Melb...